The AstaZeneca DSMB issued a statement yesterday expressing concerns about the accuracy and up-to-dateness of the efficacy data of AZD1222. The iss...

Drug firm may have provided incomplete view of efficacy data from US trial, Coronavirus · 7.4m followers Shared knowledge and experiences regarding COVID-19 Christopher VanLang, Senior Engineer in Drug Manufacturing Science Shared Mar 23 The AstaZeneca DSMB issued a statement yesterday expressing concerns about the accuracy and up-to-dateness of the efficacy data of AZD1222. The issues will likely cause a m... Read More »Loading… US agency questions AstraZeneca's Covid vaccine trial data the Guardian 68 upvotes46 comments Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared Mar 24 N=23: People who have had Covid might want to SKIP the second vaccine dose. "In individuals with a pre-existing immunity...the second vaccine dose...fail to boost humoral ... Read More »Loading… Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals bioRxiv 60 upvotes27 comments Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared Mar 25 "A massive second wave of the coronavirus is gripping Chile, despite a much-lauded vaccination program that is the best in Latin America and one of the top worldwide [#3 af... Read More »Loading… Chile in 'critical' grip of second Covid wave despite one of best vaccination rates NBC News 55 upvotes48 comments Read more in Coronavirus This email was sent by Quora (605 Castro Street, Mountain View, CA 94041). You were sent this email because you are following Coronavirus. If you don't want these updates anymore, you can unfollow Coronavirus or unsubscribehttp://www.quora.com/